 |
|
|
|
|
|
| |
Due to the 100A° pores and the big surface area of 350 m2/g the phase has an excellent preparative capacity. With a 250 x 10 mm column one can separate 50 250 mg / injection and with a 250 x 20 mm column 250 1000 mg/ injection.
The phase is stable in all commonly used normal phase eluents. Typical eluents are mixtures of Hexane and 2-Propanol. The best pH-range is between 2 und 7. The columns are stable up to 300 bar.
The peak shape of acids can be improved with 0,1 % acetic acid, the peak shape of bases with 0,1 % TEA. With 0,01% Ammonium Acetate a good peak shape can be achieved both with acids and with bases.
Examples for Separations:
The most commonly used column dimension is 250 x 4.6 mm with a flow of 1,5 ml / min
|
|
| |
Aromatic Alcohols: |
|
|
|
|
| |
Benzoin |
Eluent: Heptane / IPA ( 99/1) |
|
|
|
| |
tert-Butyl-Phenyl-Carbinol: |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
-Naphthyl-Methyl-Carbinol: |
Eluent: Hexane / IPA (99/1) |
|
|
| |
9-Anthryl-Trifluoromethyl-Carbinol: |
Eluent: Hexane / IPA (95/5) |
|
|
|
| |
Acenaphthenol: |
Eluent: Hexane / IPA (95/5) |
|
|
|
| |
1,1-2-Binaphthol: |
Eluent: Hexane / IPA + 0.1 % TFA (98/2) |
|
|
| |
9-Anthrylethanol: |
Eluent: Heptane / IPA (95/5) |
|
|
|
| |
1-Naphthyl-2-Butanol: |
Eluent: Heptane / IPA (95/5) |
|
|
|
| |
2-Naphthyl-2-Butanol: |
Eluent: Heptane / IPA (95/5) |
|
|
|
| |
1-Phenylpentanol: |
Eluent: Heptane / 1,2-Dimethoxyethane (99/1) |
|
|
| |
Phenyl-Tribromomethyl-Carbinol: |
Eluent: Hexane / IPA (99/1) |
|
|
|
| |
Phenyl-Methyl-Carbinol: |
Eluent: Hexane 100 % |
|
|
| |
Phenyl-Ethyl-Carbinol: |
Eluent: Hexane / IPA (99/1) |
|
|
| |
1,1,2-Triphenyl-1,2-Ethandiol: |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
1,1-Binapthol-Monomethylether: |
Eluent: Hexane / IPA + 0,1 % TFA (98/2) |
|
|
|
| |
trans-Phenyl-Cyclohexanol: |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
Phenyl-Cyclohexyl-Carbinol: |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
Phenyl-Isopropyl-Carbinol: |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
Phenyl-Phenylethyl-Carbinol : |
Eluent: Heptane / IPA (99/1) |
|
|
|
| |
1-Phenyl-2-Propanol: |
Eluent: Heptane / 1,2-Dimethoxyethane (98.5/1.5) |
|
|
|
| |
3-Thiophenethanol: |
Eluent: Heptane / 1,2-Dimethoxyethane (98.5/1.5) |
|
|
|
| |
1-(o-Methoxyphenyl)-Ethanol: |
Eluent: Heptane / 1,2-Dimethoxyethane (98.5/1.5) |
|
|
|
| |
1-(4-Phenyl)-Phenylethanol: |
Eluent: Heptane / 1,2-Dimethoxyethane (98.5/1.5) |
|
|
|
| |
1-(p-Methylphenyl)-Ethanol: |
Eluent: Heptane / 1,2 Dimethoxyethane (98.5/1.5) |
|
|
|
| |
1-(p-Chlorophenyl)-Ethanol: |
Eluent: Heptane / 1,2 Dimethoxyethane (98.5/1.5) |
|
|
|
| |
Vapol: |
Eluent: 100 % Methanol |
|
|
| |
Warfarin: |
Eluent: Heptane / IPA + 0,1 % TFA (70/30) |
|
|
|
| |
|
|
|
|
|
| |
|
|
| |
Other Racemate-groups: |
|
|
|
|
| |
Flobufen: |
Eluent: Heptane / IPA + 0.1 % TFA (90/10) |
|
|
|
| |
Trichlormethiazide: |
Eluent: Hexane / IPA + 0.1 % Acetic acid (75/25) |
|
|
|
| |
Prilocaine |
Eluent: Hexane / Ethanol + 0,01M Ammonium acetate (99/1) |
| |
Etodolac: |
Eluent: Hexane / IPA + 0,1 % TFA (98/2) |
|
|
|
| |
Naproxen : |
Eluent: Heptane / IPA + 0,1 % TFA (90/10) |
|
|
|
| |
Phenylbutyric acid: |
Eluent: Heptane / IPA + 0,1 % TFA (99/1) |
|
|
|
| |
Trolox: |
Eluent: Hexane / IPA + 0,1 % Acetic acid (95/5) |
|
|
|
| |
Ditoluoyltartaric acid: |
Eluent: Hexane / IPA + 0,1 % TFA (90/10) |
|
|
|
| |
Phenylsuccinic acid: |
Eluent: Hexane / IPA + 0.1 % TFA (95/5) |
|
|
|
| |
1-Cyclopentyl-1-Phenylacetic acid: |
Eluent: Hexane / IPA + 0,1 % TFA (99/1) |
|
|
|
| |
Cyclopentyl-Benzoyl-Diamide: |
Eluent: Hexane / IPA (90/10) |
|
|
|
| |
Indapamide: |
Eluent: Hexane / IPA (75/25) |
|
|
|
| |
Thalidomide: |
Eluent: Hexane / IPA + 0,1 % Acetic acid (90/10) |
|
|
|
| |
Bendroflumethiazide: |
Eluent: Hexane / IPA (75/25) |
|
|
|
| |
Cyclothiazide: |
Eluent: Hexane / IPA + 0,1 % Acetic acid (75/25) |
|
|
|
| |
|
|
|
|
|
| |
Method development for Normal-Phase Separations: |
|
|
|
| |
1.) Start off with a mixture of Hexane / IPA (90/10).
2.) If the RT is too short, add less IPA; if the RT is too long, add more IPA.
3.) Peak-Tailing
with acids: use 0,1 % Acetic acid,
with bases: use 0,1 % TEA.
You can improve the peak shapes in both cases with 0,01 % Ammonium acetate.
4.) The method can be further optimized by replacing Hexane with Heptane and / or IPA with Ethanol.
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
Examples : Reprosil Chiral-OH, 8 µm, 250 x 4.6 mm, Art.Nr.: r18.OH.s2546 |
|
|
|
| |

|
|
|
| |
|
|
| |
|
|
|
|
|
| |
back |
|
|
|
|
|
|
|
|
|
|